High Baseline Patient’s Compared with Evaluator’s Global Assessment Is Associated with Lower Retention and Remission Rates of First TNF Inhibitor in Psoriatic Arthritis Patients – Data from the EuroSpA Research Collaboration Network
14/08/2023
Brigitte Michelsen1, Lykke Midtbøll Ørnbjerg 2, Herman Mann 3, Tore Kvien 4, Michael J. Nissen 5, Maria José Santos 6, Dan Nordström 7, Lennart Jacobsson 8, Ziga Rotar 9, Bjorn Gudbjornsson 10, Süleyman Serdar Koca 11, Catalin Codreanu 12, Manuel Pombo-Suarez 13, Irene van der Horst-Bruinsma 14, Anne Gitte Loft 15, Karel Pavelka 3, Eirik Kristianslund 16, Burkhard Moeller 17, Elsa Vieira-Sousa 18, Anna Mari Hokkanen 19, Ulf Lindström 20, Matija Tomsic 21, Thorvardur J Love 22, Abdurrahman Tufan
ACR 2019
Michelsen B, Midtbøll Ørnbjerg L, Mann H, Kvien T, Nissen M, Santos M, Nordström D, Jacobsson L, Rotar Z, Gudbjornsson B, Koca S, Codreanu C, Pombo-Suarez M, van der Horst-Bruinsma I, Loft A, Pavelka K, Kristianslund E, Moeller B, Vieira-Sousa E, Hokkanen A, Lindström U, Tomsic M, Love T, Tufan A, IONESCU R, Sánchez-Piedra C, van de Sande M, Macfarlane G, Iannone F, Hyldstrup L, Østergaard M, Lund Hetland M. High Baseline Patient’s Compared with Evaluator’s Global Assessment Is Associated with Lower Retention and Remission Rates of First TNF Inhibitor in Psoriatic Arthritis Patients – Data from the EuroSpA Research Collaboration Network [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/high-baseline-patients-compared-with-evaluators-global-assessment-is-associated-with-lower-retention-and-remission-rates-of-first-tnf-inhibitor-in-psoriatic-arthritis-patients-data/
https://acrabstracts.org/abstract/high-baseline-patients-compared-with-evaluators-global-assessment-is-associated-with-lower-retention-and-remission-rates-of-first-tnf-inhibitor-in-psoriatic-arthritis-patients-data/